The advent of a new pseudoephedrine product to combat methamphetamine abuse

por Brzeczko, Albert W., Leech, Ronald, Stark, Jeffrey G.
Publicado 2013

Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy

por Anjohrin, Suzanne, Sheahan, Anna, Suruki, Robert, Stark, Jeffrey L., Sloan, Victor S.
Publicado 2021

Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review

por Magrey, Marina, Schwartzman, Sergio, de Peyrecave, Natasha, Sloan, Victor S., Stark, Jeffrey L.
Publicado 2022

A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hy...

por Childress, Ann, Newcorn, Jeffrey, Stark, Jeffrey G., McMahen, Russ, Tengler, Mark, Sikes, Carolyn
Publicado 2016

Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study

por Hwang, Mark C., Martin, Mona, Harris, Kristina, Geerdts, Philip, Stark, Jeffrey L., Reveille, John
Publicado 2020

Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study

por Yurko-Mauro, Karin, Kralovec, Jaroslav, Bailey-Hall, Eileen, Smeberg, Vanessa, Stark, Jeffrey G., Salem, Norman
Publicado 2015

Barriers to treatment optimization and achievement of patients’ goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry

por Gavigan, Kelly, Nowell, W. Benjamin, Serna, Mylene S., Stark, Jeffrey L., Yassine, Mohamed, Curtis, Jeffrey R.
Publicado 2020

Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis

por Stark, Jeffrey G., Noonan, Patrick K., Spencer, Robert H., Bhaduri, Sarbani, O’Connor, Stephen J., Menzaghi, Frédérique
Publicado 2023

Phase I studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of DS‐1211, a tissue‐nonspecific alkaline phosphatase inhibitor

por Maruyama, Sonomi, Visser, Hester, Ito, Takashi, Limsakun, Tharin, Zahir, Hamim, Ford, Daniel, Tao, Ben, Zamora, Cynthia A., Stark, Jeffrey G., Chou, Hubert S.
Publicado 2022

Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry

por McLean, Robert R., Sima, Adam P., Beaty, Silky, Low, Robert, Spitzer, Rebecca L., Stark, Jeffrey L., Lesser, Elizabeth, Lee, Edward, Armstrong, April
Publicado 2023

The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases

por Curtis, Jeffrey R., Winthrop, Kevin, Bohn, Rhonda L., Suruki, Robert, Siegel, Sarah, Stark, Jeffrey L., Xie, Fenglong, Yun, Huifeng, Chen, Lang, Deodhar, Atul
Publicado 2021

Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry

por McLean, Robert R., Sima, Adam P., Beaty, Silky, Jones, Eric A., Eckmann, Thomas, Low, Robert, McClung, Laura, Spitzer, Rebecca L., Stark, Jeffrey, Armstrong, April
Publicado 2023

One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid a...

por Harrold, Leslie R., Litman, Heather J., Saunders, Katherine C., Dandreo, Kimberly J., Gershenson, Bernice, Greenberg, Jeffrey D., Low, Robert, Stark, Jeffrey, Suruki, Robert, Jaganathan, Srihari, Kremer, Joel M., Yassine, Mohamed
Publicado 2018